Video
The Itch Factor: Why Relief Can’t Wait in Atopic Dermatitis
Podcast
Shedding New Light on Phototherapy: Now in the Comfort of Your Own Home
Feat. E. James Song, MD
CME
CMEswiper: Swipe to See CLE: Recognition and Diagnosis of Cutaneous Lupus Erythematosus: An Online Activity
With Victoria Werth, MD
Case Study
Jacked on JAKs: The Therapeutic Impact of Dose Escalation in a Case of Refractory Atopic Dermatitis
By Graham Litchman, DO, MS
Innovation Corner
Innovation Corner
Continue Your Learning Journey
Pooled Phase 3 Data With Remibrutinib in Chronic Spontaneous Urticaria
By Authors: Sarbjit Saini, Giselle Mosnaim, Ana Giménez-Arnau, Linfeng Li, El-Djouher Martzloff, Alis Burciu, Karine Lheritier, Martin Metz
Disease Activity With Remibrutinib in Chronic Spontaneous Urticaria
By Authors: Martin Metz, Ana M. Giménez-Arnau, Petra Staubach, Marta Ferrer Puga, Kanokvalai Kulthanan, Xinghua Gao, Karine Lheritier, Christine-Elke Ortmann, Nadine Chapman-Rothe, Sibylle Haemmerle, Atsushi Fukunaga, Michihiro Hide
Botulinum Toxin Safe, Effective for Refractory Digital Ischemia
By Dermsquared Editorial Team | December 12, 2025
Long-Term Durable Responses to Cemiplimab Seen in Advanced CSCC
By Dermsquared Editorial Team | December 12, 2025
Rocatinlimab Yields Significant Improvements in Atopic Dermatitis
By Elana Gotkine (HealthDay News) | December 12, 2025
RSNA: Ultrasound Findings Can ID Cosmetic Filler-Linked Vascular Adverse Events
By Elana Gotkine (HealthDay News) | December 12, 2025
CatBoost Model Has Best Performance for Predicting Survival in Melanoma
By Dermsquared Editorial Team | December 11, 2025
Dermatoscopes Compared for Dermoscopy Performance, Teledermatology Use
By Dermsquared Editorial Team | December 11, 2025
FDA Approves Updated Label for Unloxcyt
By Lori Solomon (HealthDay News) | December 11, 2025
Slight Increase in Global Burden of Psoriasis Seen Through 2021
By Dermsquared Editorial Team | November 26, 2025




























































































































